In January 2023, eLife changed its model of publishing. The main point: "There is no accept/reject decision after peer review: rather, every article we review is published on the eLife website as a Reviewed Preprint that includes an eLife assessment, public reviews, and a response from the authors (if available)."
eLife is a very good journal, but I am not sure if I should publish with it now. People may consider it just another preprint server, and may not take papers there seriously. Also, the impact factor of the journal may decline quickly. (Yes, I am aware that IF has its flaws, but still a widely used indicator to judge a paper quickly.)
What are the ramifications of eLife's new publication policy?